Skeletal muscle 11β hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 249-255

  Jang, Christina ^a,b   Obeyesekere, Varuni R ^a   Alford, Frank P ^a,b   Inder, Warrick J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROCORTISONE; INSULIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; HSD11B1 PROTEIN, HUMAN;

ABDOMINAL SURGERY; ADULT; ARTICLE; BODY MASS; CHOLECYSTECTOMY; CLINICAL ARTICLE; ELECTIVE SURGERY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; MUSCLE BIOPSY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UPREGULATION; VASTUS LATERALIS MUSCLE; ABDOMEN; BLOOD; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ABDOMEN; ADULT; BLOOD GLUCOSE; CHOLECYSTECTOMY; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROCORTISONE; INSULIN; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 61449231714     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0619     Document Type: Article

References (36)

1. Naito Y, Tamai S, Shingu K, Shindo K, Matsui T, Segawa H, Nakai Y & Mori K. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 1992 77 426-431.
2. Udelsman R, Norton JA, Jelenich SE, Goldstein DS, Linehan WM, Loriaux DL & Chrousos GP. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. Journal of Clinical Endocrinology and Metabolism 1987 64 986-994.
3. Naito Y, Fukata J, Tamai S, Seo N, Nakai Y, Mori K & Imura H. Biphasic changes in hypothalamo-pituitary-adrenal function during the early recovery period after major abdominal surgery. Journal of Clinical Endocrinology and Metabolism 1991 73 111-117.
4. Donald RA, Perry EG, Wittert GA, Chapman M, Livesey JH, Ellis MJ, Evans MJ, Yandle T & Espiner EA. The plasma ACTH, AVP, CRH and catecholamine responses to conventional and laparoscopic cholecystectomy. Clinical Endocrinology 1993 38 609-615.
5. Thorell A, Efendic S, Gutniak M, Haggmark T & Ljungqvist O. Insulin resistance after abdominal surgery. British Journal of Surgery 1994 81 59-63.
6. Hawthorne GC, Ashworth L & Alberti KG. The effect of laparoscopic cholecystectomy on insulin sensitivity. Hormone and Metabolic Research 1994 26 474-477.
7. Thorell A, Nygren J, Essen P, Gutniak M, Loftenius A, Andersson B & Ljungqvist O. The metabolic response to cholecystectomy: insulin resistance after open compared with laparoscopic operation. European Journal of Surgery 1996 162 187-191.
8. Thorell A, Nygren J, Hirshman MF, Hayashi T, Nair KS, Horton ES, Goodyear LJ & Ljungqvist O. Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization. American Journal of Physiology 1999 276 E754-E761.
9. Ljungqvist O, Nygren J & Thorell A. Insulin resistance and elective surgery. Surgery 2000 128 757-760.
10. Chaudhary D, Verma GR, Gupta R, Bose SM & Ganguly NK. Comparative evaluation of the inflammatory mediators in patients undergoing laparoscopic versus conventional cholecystectomy. Australian and New Zealand Journal of Surgery 1999 69 369-372.
11. Kristiansson M, Saraste L, Soop M, Sundqvist KG & Thorne A. Diminished interleukin-6 and C-reactive protein responses to laparoscopic versus open cholecystectomy. Acta Anaesthesiologica Scandinavica 1999 43 146-152.
12. Stewart PM & Whorwood CB. 11 β-Hydroxysteroid dehydrogenase activity and corticosteroid hormone action. Steroids 1994 59 90-95.
13. Jang C, Obeyesekere VR, Dilley RJ, Krozowski Z, Inder WJ & Alford FP. Altered activity of 11b-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2007 92 3314-3320.
14. Alberti KG, Zimmet P & Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 1059-1062.
15. Christopher M, Hew FL, Oakley M, Rantzau C & Alford F. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Journal of Clinical Endocrinology and Metabolism 1998 83 1668-1681.
16. Mclachlan KA & Alford FP. The impact of acute elevation of nonesterified fatty acids on insulin sensitivity and secretion in women with former gestational diabetes. Clinical Endocrinology 2005 62 79-84.
17. Levy JC, Matthews DR & Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 2191-2192.
18. Eisenhardt S, Schwarzmann N, Henschel V, Germeyer A, Von Wolff M, Hamann A & Strowitzki T. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2006 91 946-952.
19. Jang C, Obeyesekere VR, Dilley RJ, Alford FP & Inder WJ. 11β hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clinical Endocrinology 2006 65 800-805.
20. Glanemann C, Loos A, Gorret N,Willis LB, O'Brien XM, Lessard PA & Sinskey AJ. Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis. Applied Microbiology and Biotechnology 2003 61 61-68.
21. Pachucki J, Ambroziak M, Tanski Z, Luczak J, Nauman J & Nauman A. Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. Journal of Endocrinological Investigation 2001 24 253-261.
22. Andrew R, Smith K, Jones GC & Walker BR. Distinguishing the activities of 11β-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. Journal of Clinical Endocrinology and Metabolism 2002 87 277-285.
23. Basu R, Singh RJ, Basu A, Chittilapilly EG, Johnson CM, Toffolo G, Cobelli C & Rizza RA. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase type 1 pathway. Diabetes 2004 53 2051-2059.
24. Ortega AE, Peters JH, Incarbone R, Estrada L, Ehsan A, Kwan Y, Spencer CJ, Moore-Jeffries E, Kuchta K & Nicoloff JT. A prospective randomized comparison of the metabolic and stress hormonal responses of laparoscopic and open cholecystectomy. Journal of the American College of Surgeons 1996 183 249-256.
25. Majeed AW, Troy G, Nicholl JP, Smythe A, Reed MW, Stoddard CJ, Peacock J & Johnson AG. Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. Lancet 1996 347 989-994.
26. Ruzzin J, Wagman AS & Jensen J. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 2005 48 2119-2130.
27. Bloom SR, Edwards AV & Jones CT. Neuroendocrine responses to stimulation of the splanchnic nerves in bursts in conscious, adrenalectomized, weaned lambs. Journal of Physiology 1989 417 79-89.
28. Martin IK, Weber KM, Boston RC, Alford FP & Best JD. Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs. American Journal of Physiology 1988 255 E668-E673.
29. Wake DJ, Homer NZ, Andrew R & Walker BR. Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. Journal of Clinical Endocrinology and Metabolism 2006 91 4682-4688.
30. Saranteas T, Voukena V, Zotos N, Stranomiti J, Kondadaki A, Tachmintzi A, Pantos C, Tesseromatis C & Dimitriou V. Lipid kinetics in obese patients undergoing laparoscopy. The impact of cortisol inhibition by etomidate. European Journal of Drug Metabolism and Pharmacokinetics 2004 29 187-192.
31. Targarona EM, Pons MJ, Balague C, Espert JJ, Moral A, Martinez J, Gaya J, Filella X, Rivera F, Ballesta A & Trias M. Acute phase is the only significantly reduced component of the injury response after laparoscopic cholecystectomy. World Journal of Surgery 1996 20 528-533.
32. Leung K & Munck A. Peripheral actions of glucocorticoids. Annual Review of Physiology 1975 37 245-272.
33. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M & Stewart PM. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001 142 1982-1989.
34. Bujalska IJ, Kumar S, Hewison M & Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11betahydroxysteroid dehydrogenase. Endocrinology 1999 140 3188-3196.
35. Escher G, Galli I, Vishwanath BS, Frey BM & Frey FJ. Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. Journal of Experimental Medicine 1997 186 189-198.
36. Helmy SA, Wahby MA & El-Nawaway M. The effect of anaesthesia and surgery on plasma cytokine production. Anaesthesia 1999 54 733-738.